Iproteos
Biotechnology company determined to improve human health by creating therapeutics for unmet medical needs in the central nervous system space.
Employees
Enterprise value
$7—10m
- biotechnology
- horizon europe
- dt and ls
- woman founder
- spinout
- biotech and pharma
- eit ecosystem
- neurology
- drug development
- eit health
- innovation management
- eit supernovas
- chemistry
- european health catapult (eit health)
- investor network (eit health)
- investor network 2018 (eit health)
- european health catapult 2019 (eit health)
- epilepsy
loading funding rounds…
Criteria Venture Tech(exited)
ASCIL Biopharm(exited)
Kinled Holding(exited)
EIT Health(exited)
University of Barcelona(exited)
Caixa Capital Risc(exited)
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (65 %) | 262 % | (90 %) | (60 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 66 % | (415 %) | (51 %) | (682 %) | (3229 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (32 %) | (645 %) | (136 %) | (2412 %) | (13064 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.